Literature DB >> 9796850

Fibromyalgia in Indian patients with SLE.

R Handa1, P Aggarwal, J P Wali, N Wig, S N Dwivedi.   

Abstract

One hundred and fifty-eight patients with SLE were prospectively studied at a tertiary referral centre in India to ascertain the prevalence and clinical profile of fibromyalgia (FM) in Indian patients with lupus. An attempt was made to determine whether socio-demographic factors or disease characteristics differ in SLE patients with and without FM. Only 13 patients (8.2%) in our cohort were found to have fibromyalgia. Their clinical profiles were similar to that reported in other series. Corticosteroid withdrawal or dose reduction was the probable precipitating factor in nearly one-third of our patients. Age, sex, marital status, educational level, disease duration, disease activity and the organ involvement in patients with SLE and FM were comparable to those in patients not having FM. Fibromyalgia appears to be distinctly uncommon in Indian patients with lupus. A strong family support system, the virtual lack of disability benefits and/or racial variations in pain threshold could be the likely factors responsible for the low prevalence of the disease observed in Indian patients with SLE.

Entities:  

Mesh:

Year:  1998        PMID: 9796850     DOI: 10.1191/096120398678920497

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  Fatigue and its correlates in Indian patients with systemic lupus erythematosus.

Authors:  Benzeeta Pinto; Aadhaar Dhooria; Sandeep Grover; Meenakshi Jolly; John Michael Raj; Aman Sharma
Journal:  Clin Rheumatol       Date:  2020-10-08       Impact factor: 2.980

Review 2.  Are patients with systemic lupus erythematosus at increased risk for fibromyalgia?

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

Review 3.  Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications.

Authors:  Dan Buskila; Joseph Press; Mahmoud Abu-Shakra
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

4.  Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.

Authors:  Frederick Wolfe; Michelle Petri; Graciela S Alarcón; John Goldman; Eliza F Chakravarty; Robert S Katz; Elizabeth W Karlson
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

5.  The prevalence of fibromyalgia in other chronic pain conditions.

Authors:  Muhammad B Yunus
Journal:  Pain Res Treat       Date:  2011-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.